Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

ENCORAFENIB (BRAFTOVI) 75 mg Capsules

Northern Health and Social Care Trust

This public procurement record has 3 releases in its history.

Award

10 Sep 2026 at 13:09

UK7 - Contract Details Notice
Award

17 Aug 2026 at 14:22

UK6 - Contract Award Notice
Award

17 Aug 2026 at 14:16

UK5 - Transparency Notice
Summary of the contracting process

Northern Health and Social Care Trust procured the supply of encorafenib (BRAFTOVI) 75 mg capsules, a pharmaceutical product used within the Trust’s healthcare services. The requirement covers the medicine itself rather than associated clinical, logistics or treatment services. Delivery is for the Trust’s activities in Northern Ireland. The procurement is categorised as goods and concerns a single requirement. The named buyer is Northern Health and Social Care Trust, based in Antrim. The awarded supplier is Pierre Fabre Limited, a large pharmaceutical company. The product is identified under CPV 33600000, pharmaceutical products, and the requirement was treated as a single lot.

This procurement is complete and has been awarded through a direct award. The contract was awarded to Pierre Fabre Limited on 17 August 2026 for £180,000 excluding VAT, or £216,000 including VAT. The contract was signed on 10 September 2026 and runs from 1 September 2026 to 31 August 2029, for up to three years. The award followed a single-supplier intellectual-property and exclusive-rights route under section 41 and Schedule 5(5) of the Procurement Act 2023. The Trust stated that the product is commercially available only from one supplier, because of patent protection or sole marketing authorisation, and that no reasonable alternative or substitute exists. The award value is above the relevant threshold.

For a supplier assessing future pharmaceutical requirements from this buyer, the procurement indicates demand for specialist oncology medicines supplied under exclusive intellectual-property or marketing-authorisation arrangements. A credible competitor would need to hold, control or lawfully distribute the relevant patented product, demonstrate the necessary rights to supply it in the UK, and provide reliable pharmaceutical supply to a Northern Ireland health and social care organisation. The requirement also shows that the buyer may use a direct-award route where a medicine is available from only one commercial source and no reasonable substitute exists. Suppliers with comparable branded medicines, exclusive distribution rights or established public-sector pharmaceutical supply capability may find this buyer’s future medicine requirements commercially relevant.

How relevant is this notice?

Notice Information

Notice Title

ENCORAFENIB (BRAFTOVI) 75 mg Capsules

Notice Description

Contract for supply of ENCORAFENIB (BRAFTOVI) 75 mg Capsules for a period of up to 3 years

Procurement Information

Purchase of drugs which are subject to patent protection/ Sole MA Holder, where no reasonable alternative or substitute exists. Section 41 schedule 5(5) of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract - (a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods,services or works. The product required is only commercially available from one supplier and no competition or alternative exists for this product.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06e5aa
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/085874-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£180,000 £100K-£500K
Contracts Value
£180,000 £100K-£500K

Notice Dates

Publication Date
10 Sep 20261 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
17 Aug 20262 months ago
Contract Period
10 Sep 2026 - 31 Aug 2029 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Northern Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
ANTRIM
Postcode
BT41 2RL
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN0D Antrim and Newtownabbey
Delivery Location
Not specified
Local Authority
Antrim and Newtownabbey
Electoral Ward
Springfarm
Westminster Constituency
South Antrim

Supplier Information

Number of Suppliers
1
Supplier Name

Pierre Fabre Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...